| Literature DB >> 32333285 |
Qian Shen1, Mo Wang2, Ruochen Che3, Qiu Li2, Jianhua Zhou4, Fang Wang5, Ying Shen6, Jie Ding5, Songming Huang3, Hui-Kim Yap7, Bradley A Warady8, Hong Xu9, Aihua Zhang10.
Abstract
Coronavirus disease 2019 (COVID-19) has rapidly spread not only in China but throughout the world. Children with kidney failure (chronic kidney disease (CKD) stage 5) are at significant risk for COVID-19. In turn, a set of recommendations for the prevention and control of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 in pediatric hemodialysis (HD) centers and in home peritoneal dialysis (PD) settings have been proposed. The recommendations are based on the epidemiological features of the SARS-CoV-2 virus and COVID-19 disease, susceptibility factors, and preventive and control strategies. These recommendations will be updated as new information regarding SARS-CoV-2 and COVID-19 becomes available.Entities:
Keywords: COVID-19; Children; Dialysis; SARS-CoV-2
Mesh:
Year: 2020 PMID: 32333285 PMCID: PMC7181108 DOI: 10.1007/s00467-020-04555-x
Source DB: PubMed Journal: Pediatr Nephrol ISSN: 0931-041X Impact factor: 3.714
Diagnostic classifications of COVID-19 (based on data from [7])
| Epidemiological history | a. A history of travel or residence in areas with a wide spread diffusion of COVID-19 within 14 days prior to the onset of symptoms. b. Direct contact with SARS-CoV-2-infected individual (positive nucleic acid test) within 14 days before the onset of symptoms. c. Direct contact with a patient who has symptoms of fever and/or respiratory infection from areas with a wide spread diffusion of COVID-19 within 14 days prior to the onset of symptoms. d. Cluster onset. |
| Clinical manifestations | a. Fever and/or respiratory symptoms. b. Pulmonary imaging with signs of COVID-19. c. Laboratory tests suggesting early stage of disease: total white blood cell count normal or decreased with decreased lymphocyte count. |
| Suspected case | Individual who meets one of the epidemiological history criteria combined with two of the clinical manifestations, or who meets all three of the clinical manifestations. |
| Confirmed case | Suspected case with RT-PCR positive detection of SARS-CoV-2 nucleic acid, or highly homologous viral gene sequencing to the known SARS-Cov-2. |
SARS-CoV-2 infection prophylactic strategies for HD healthcare staff
| Healthcare staff training | Regularly provided updated information about COVID-19 |
| Epidemic history surveillance | Any close contact with suspected/confirmed cases or epidemic area should be reported |
| Body temperature monitor | Body temperature and any symptoms should be monitored |
| Personal protective equipment [ | Disposable surgical or N95 masks and caps are required. HD for medical observation cases: PPE performed according to the second level of protection standard, including N95 mask, cap, protective gown, goggles or face shield, shoe covers, and gloves. HD for suspected or confirmed cases: PPE performed according to the third level of protection standard, including N95 mask, cap, protective gown, powered air purifying respirator, shoe covers, and gloves. |
| Hand hygiene | Performed in accordance with the “Five Moments for Hand Hygiene” as recommended by the WHO |
| Adequate rest | Adequate rest should be guaranteed |
SARS-CoV-2 infection prophylactic strategies for HD patients
| Patient education | Provide basic knowledge of COVID-19 and repeated education of recommended infection prevention practices |
| Remote medical care | Medical consultations by phone or on-line to be encouraged |
| Epidemic history surveillance | Any close contact with suspected/confirmed cases or with history of presence in epidemic area should be reported; this includes patients and companions |
| Body temperature monitor | Body temperature and any symptoms should be monitored both for patients and companions |
| Personal protective equipment | Patients should be instructed to wear a disposable general medical mask or a surgical mask during the HD treatment |
| Limiting accompanying persons | One child should be accompanied by only one caregiver, who would be allowed to enter into dialysis area only in special situations. Keeping the same accompanying person is recommended. |
| Inter-center transfer avoidance | Unnecessary transfer from other dialysis centers is to be avoided |
SARS-CoV-2 infection prophylactic strategies for HD facility
| Increased disinfect frequency | Disinfection measures should be performed between each shift of dialysis and after all patient treatments |
| Disinfection of all the items and floor | Recommended concentrations of chlorine-containing disinfectant should be utilized for 30 min |
| Disinfection of the air | Disinfection by ultraviolet light should be conducted for more than 30 min |
| Fixed dialysis machine | If possible, one child should use the same dialysis machine at every treatment |
| Proper design of HD unit layout | The separation between two HD beds/chairs should be at least 1 m; curtains should be drawn around patient during HD treatments. |
SARS-CoV-2 infection prophylactic strategies for home PD patients
| Home environment management | Air the room at least twice a day for 30 min each time. Sweep and clean the floor before the PD treatment once a day, and then carry out ultraviolet disinfection. Before and after each PD treatment, use 75% alcohol wet cloth to wipe the procedure table or APD machine (as appropriate for patient). |
| Patient management | Learn the SARS-CoV-2 infection prevention information. Strictly perform hand hygiene and PPE. Disinfection of drainage fluid with 500 mg/L chlorine-containing solution for 1 h. Online medical consultation for home PD. |